Evidence map›Paper›PMID 41390656›Full record

ReviewJournal of biological engineering2025

Development of a semi-endogenous PRT-based expression system for Methylotuvimicrobium alcaliphilum and its application to enhance 3-hydroxybutyric acid production from methanol.

Khoi Nhat Pham, Eun Yeol Lee

Abstract readReview
In one paragraph

Review in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Khoi Nhat PhamDepartment of Chemical Engineering (BK21 FOUR Integrated Engineering), Kyung Hee University, Yongin-si, Gyeonggi-do, 17104, Republic of Korea.
Eun Yeol LeeDepartment of Chemical Engineering (BK21 FOUR Integrated Engineering), Kyung Hee University, Yongin-si, Gyeonggi-do, 17104, Republic of Korea. eunylee@khu.ac.kr.

Funding

National Research Foundation of Korea RS-2025-02214232, RS-2024-00466473
6 · The paper itself

Abstract

backgroundEndogenous expression systems, such as those incorporating promoters, ribosome-binding sites (RBS), and terminators (i.e., PRT systems), have been developed for various bacterial host strains. However, intact native promoters are typically long sequences that include regulated regions, which hinder the production of recombinant proteins.

resultsIn this study, a semi-endogenous PRT system based on 20-40 nucleotide motif sequences derived from the genome of the target host strains was developed using machine learning-based prediction tools. This system was subsequently fine-tuned and optimized based on transcription and translation rates as well as the Gibbs free energy of the terminator structure. This system was validated, and its effectiveness was demonstrated by using it to induce the expression of dTomato, ZeocinR, and phaCAB cluster genes in E. coli. The semi-endogenous PRT was also used for enhanced production of 303 ± 6.39 mg/L 3-hydroxybutyric acid (3-HB) from methanol as the sole carbon source in a 50-mL nitrate mineral salt (NMS) flask after 234 h with overexpression of exogenous phaA and phaB genes in the Methylotuvimicrobium alcaliphilum 20ZX strain.

conclusionsThe semi-endogenous PRT system was efficiently designed and served as an endogenous expression system in both E. coli and methanotroph. This system will offer more choices for selecting an endogenous expression platform tailored to the target host strain.

Indexed as

3-hydroxybutyric acidMethanolMethanotrophRibosome-binding siteSemi-endogenous promoterTerminator

Identifiers

PMID41390656
PMCPMC12817867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.